Authors: Kong, JW Hamann, LG Ruppar, DA Edwards, JP Marschke, KB Jones, TK

Citation: Jw. Kong et al., Effects of isosteric pyridone replacements in androgen receptor antagonists based on 1,2-dihydro- and 1,2,3,4-tetrahydro-2,2-dimethyl-6-trifluoromethyl-8-pyridono[5,6-g]quinolines, BIOORG MED, 10(5), 2000, pp. 411-414

Authors: Hamann, LG

Citation: Lg. Hamann, An efficient, stereospecific synthesis of the dimer-selective retinoid X receptor modulator (2E,4E,6Z)-7-[5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-(n-propyloxy)naphthalen-3-yl]-3-methylocta-2,4,6-trienoic acid, J ORG CHEM, 65(10), 2000, pp. 3233-3235

Authors: Higuchi, RI Edwards, JP Caferro, TR Ringgenberg, JD Kong, JW Hamann, LG Arienti, KL Marschke, KB Davis, RL Farmer, LJ Jones, TK

Citation: Ri. Higuchi et al., 4-alkyl- and 3,4-dialkyl-1,2,3,4-tetrahydro-8-pyridono [5,6-g]quinolines: Potent, nonsteroidal androgen receptor agonists, BIOORG MED, 9(9), 1999, pp. 1335-1340

Authors: Edwards, JP Higuchi, RI Winn, DT Pooley, CLF Caferro, TR Hamann, LG Zhi, L Marschke, KB Goldman, ME Jones, TK

Citation: Jp. Edwards et al., Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, BIOORG MED, 9(7), 1999, pp. 1003-1008

Authors: Hamann, LG Mani, NS Davis, RL Wang, XN Marschke, KB Jones, TK

Citation: Lg. Hamann et al., Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6(trifluoromethyl)-8-pyridono[5,6-g]-quinoline (LG121071), J MED CHEM, 42(2), 1999, pp. 210-212